Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma (Q33426556)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma |
scientific article |
Statements
1 reference
Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma (English)
1 reference
Andrew Gabrielson
1 reference
Anteneh A Tesfaye
1 reference
John L Marshall
1 reference
Michael J Pishvaian
1 reference
Brandon Smaglo
1 reference
Reena Jha
1 reference
Karen Dorsch-Vogel
1 reference
Hongkun Wang
1 reference
Aiwu Ruth He
1 reference
8 October 2015
1 reference
1 reference
76
1 reference
1073-1079
1 reference
8 October 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference